Rubius Therapeutics Inc.

NASDAQ: RUBY · Real-Time Price · USD
0.06
0.00 (8.11%)
At close: Dec 29, 2023, 9:49 PM

Rubius Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-20.14M -62.87M -44.24M -52.41M -55.02M -49.02M -50.18M -42.33M
Depreciation & Amortization
427K 2.67M 1.6M 1.56M 3.39M 1.32M 1.52M 1.5M
Stock-Based Compensation
-1.32M 3.8M 5.04M 8.26M 9.18M 8.19M 9.6M 8.64M
Other Working Capital
-11.14M 5.5M 2.77M -4.84M 1.9M 1.88M 3.6M -6.54M
Other Non-Cash Items
6.91M 17.89M 36K 179K 244K 229K 114K 693K
Deferred Income Tax
n/a n/a n/a n/a n/a 8K 49K 61K
Change in Working Capital
-18.4M 2.31M 3.28M -4.72M 4.99M 4.83M 4.18M -7.3M
Operating Cash Flow
-32.52M -36.2M -34.29M -47.13M -37.22M -34.45M -34.72M -38.74M
Capital Expenditures
-266K -873K -1.76M -2.4M -1.37M -689K -843K -748K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-5.18M n/a n/a -78.44M n/a n/a n/a n/a
Sales Maturities Of Investments
5.18M 78.75M n/a n/a -85M 15M 27.5M 42.5M
Other Investing Acitivies
17.94M n/a n/a n/a 85M n/a n/a n/a
Investing Cash Flow
17.68M 77.88M -1.76M -80.85M -1.37M 14.31M 26.66M 41.75M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-75.7M n/a 156K 76K 416K 919K 3.21M 193.91M
Financial Cash Flow
-75.7M n/a 156K 76K 416K 919K 3.21M 193.91M
Net Cash Flow
-90.54M 41.67M -35.89M -127.91M -38.17M -19.22M -4.85M 196.92M
Free Cash Flow
-32.78M -37.08M -36.05M -49.54M -38.59M -35.13M -35.56M -39.49M